Topotecan and Melphalan for Retinoblastoma

Recruiting now · Phase 3

Conditions studied: Retinoblastoma, Chemotherapy Effect

In brief

The purpose of this study is to evaluate topotecan and melphalan for retinoblastoma patients.

Key facts

Study ID

NCT04799002

Run by

Sun Yat-sen University

People needed

50

Starts

2021-03-11

Expected to finish

2027-12-30

Last updated by the study team

2021-03-16

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosed as retinoblastoma
• receiving eyeball-sparing treatment

You may not qualify if…

• disease progression during follow-up

Where it is running

• Sun Yat-sen University — Guangzhou, Guangdong, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.